חזרה לתוצאות החיפוש

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Advanced Fallopian Tube Carcinoma · Advanced Fallopian Tube High Grade Serous Adenocarcinoma · Advanced Ovarian Carcinoma · Advanced Ovarian Carcinosarcoma · Advanced Ovarian Clear Cell Adenocarcinoma · Advanced Ovarian Endometrioid Adenocarcinoma · Advanced Ovarian High Grade Serous Adenocarcinoma · Advanced Primary Peritoneal Carcinoma · Advanced Primary Peritoneal High Grade Serous Adenocarcinoma · Fallopian Tube Carcinosarcoma · Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Endometrioid Adenocarcinoma · FIGO Stage III Ovarian Cancer 2014 · FIGO Stage IV Ovarian Cancer 2014 · Ovarian Mixed Cell Adenocarcinoma · Primary Peritoneal Carcinosarcoma · Primary Peritoneal Clear Cell Adenocarcinoma · Primary Peritoneal Endometrioid Adenocarcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Mayo Clinic in Arizona, Scottsdale, Arizona, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Nina J. Karlin, MD)

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Gerardo Colon-Otero, MD)

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Matthew S. Block, MD, PhD)
מובילי המחקר

  • Matthew S. Block, MD, PhD

    Principal Investigator

    Mayo Clinic in Rochester

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)